Mezofy
Active Ingredient(s): AripiprazoleFDA Approved: * April 15, 2025
Pharm Company: * CMG PHARM CO LTD
Category: Antipsychotic
Aripiprazole, sold under the brand names Abilify and Aristada among others, is an atypical antipsychotic.[5] It is primarily used in the treatment of schizophrenia and bipolar disorder.[5] Other uses include as an add-on treatment in major depressive disorder, tic disorders and irritability associated with autism.[5] It is taken by mouth or injection into a muscle.[5] A Cochrane review found evidence of effectiveness in treating ... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.